{"id":9985,"date":"2021-05-13T16:32:54","date_gmt":"2021-05-13T20:32:54","guid":{"rendered":"https:\/\/www.silverlaw.com\/blog\/?p=9985"},"modified":"2021-05-13T16:32:54","modified_gmt":"2021-05-13T20:32:54","slug":"anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy","status":"publish","type":"post","link":"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/","title":{"rendered":"Anixa Biosciences (ANIX) Subject To FDA Clinical Hold On Cancer Therapy"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-9986 size-full\" src=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/05\/Anixa-Biosciences-ANIX.jpg\" alt=\"Anixa Biosciences, Inc. (ANIX) is being investigated by Silver Law Group regarding potential claims for investors in the company to recover losses. The investigation concerns potential violations of the federal securities laws.  If you have losses from investing in Anixa Biosciences (ANIX) contact Silver Law Group for a no-cost consultation at (800) 975-4345 or at ssilver@silverlaw.com.  Anixa Biosciences, Inc. is a publicly-traded biotechnology company focused on the treatment of infectious diseases as well as cancer. The company focuses on significant deficiencies in the treatment of both oncology and infectious diseases. The company is also currently working on a potential treatment for COVID-19.  One of Anixa\u2019s most important projects is the Chimeric Antigen Receptor-T cell therapy (CAR-T), also called CER-T. This therapy targets the follicle stimulating hormone receptor, or FSHR. The firm has a partnership with the Moffitt Cancer Center, as well as an alliance with the Cleveland Clinic for its advanced breast cancer vaccine technology.\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/05\/Anixa-Biosciences-ANIX.jpg 300w, https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/05\/Anixa-Biosciences-ANIX-180x120.jpg 180w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>Anixa Biosciences, Inc. (ANIX) is being investigated by Silver Law Group regarding potential claims for investors in the company to recover losses. The investigation concerns potential violations of the federal securities laws.<\/p>\n<p><strong>If you have losses from investing in Anixa Biosciences (ANIX) contact Silver Law Group for a no-cost consultation at (800) 975-4345 or at <\/strong><a href=\"mailto:ssilver@silverlaw.com\" target=\"_blank\"><strong>ssilver@silverlaw.com<\/strong><\/a><strong>. <\/strong> <a href=\"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/#more-9985\" class=\"more-link\">Continue reading \u203a<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Anixa Biosciences, Inc. (ANIX) is being investigated by Silver Law Group regarding potential claims for investors in the company to recover losses. The investigation concerns potential violations of the federal securities laws. If you have losses from investing in Anixa Biosciences (ANIX) contact Silver Law Group for a no-cost consultation at (800) 975-4345 or at [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[602],"tags":[],"class_list":["post-9985","post","type-post","status-publish","format-standard","hentry","category-class-action"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anixa Biosciences (ANIX) Subject To FDA Hold On Cancer Therapy<\/title>\n<meta name=\"description\" content=\"Anixa Biosciences (ANIX) is being investigated by Silver Law Group regarding potential claims for investors in the company to recover losses.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Anixa Biosciences (ANIX) Subject To FDA Hold On Cancer Therapy\" \/>\n<meta name=\"twitter:description\" content=\"Anixa Biosciences (ANIX) is being investigated by Silver Law Group regarding potential claims for investors in the company to recover losses.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/05\/Anixa-Biosciences-ANIX.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Silver Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anixa Biosciences (ANIX) Subject To FDA Hold On Cancer Therapy","description":"Anixa Biosciences (ANIX) is being investigated by Silver Law Group regarding potential claims for investors in the company to recover losses.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/","twitter_card":"summary_large_image","twitter_title":"Anixa Biosciences (ANIX) Subject To FDA Hold On Cancer Therapy","twitter_description":"Anixa Biosciences (ANIX) is being investigated by Silver Law Group regarding potential claims for investors in the company to recover losses.","twitter_image":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/05\/Anixa-Biosciences-ANIX.jpg","twitter_misc":{"Written by":"Silver Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/#article","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/"},"author":{"name":"Silver Law Group","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"headline":"Anixa Biosciences (ANIX) Subject To FDA Clinical Hold On Cancer Therapy","datePublished":"2021-05-13T20:32:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/"},"wordCount":636,"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/05\/Anixa-Biosciences-ANIX.jpg","articleSection":["Class Action"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/","url":"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/","name":"Anixa Biosciences (ANIX) Subject To FDA Hold On Cancer Therapy","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/#primaryimage"},"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/05\/Anixa-Biosciences-ANIX.jpg","datePublished":"2021-05-13T20:32:54+00:00","author":{"@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"description":"Anixa Biosciences (ANIX) is being investigated by Silver Law Group regarding potential claims for investors in the company to recover losses.","breadcrumb":{"@id":"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/#primaryimage","url":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/05\/Anixa-Biosciences-ANIX.jpg","contentUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2021\/05\/Anixa-Biosciences-ANIX.jpg","width":300,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/www.silverlaw.com\/blog\/anixa-biosciences-anix-subject-to-fda-clinical-hold-on-cancer-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.silverlaw.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Anixa Biosciences (ANIX) Subject To FDA Clinical Hold On Cancer Therapy"}]},{"@type":"WebSite","@id":"https:\/\/www.silverlaw.com\/blog\/#website","url":"https:\/\/www.silverlaw.com\/blog\/","name":"Securities Arbitration Lawyers Blog","description":"Published by Securities Arbitration Lawyers \u2014 Silver Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.silverlaw.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752","name":"Silver Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","caption":"Silver Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/9985","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/comments?post=9985"}],"version-history":[{"count":1,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/9985\/revisions"}],"predecessor-version":[{"id":9987,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/9985\/revisions\/9987"}],"wp:attachment":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/media?parent=9985"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/categories?post=9985"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/tags?post=9985"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}